Loading…
avatar for Emily Freeman

Emily Freeman

Sanofi
Senior Director, Global Regulatory Behavioral Science
Dr. Emily Freeman is experienced patient centered science leader with a primary goal of accelerating the adoption of social/behavioral sciences within the pharmaceutical industry. She has worked to ensure the patient experience is incorporated into key regulatory decisions informing drug development with a focus on qualitative health research methods. Her research has focused on the impact of shared treatment decision-making on the quality of care received by patients and using shared decision-making as a tool for patient engagement and communication. Currently Dr. Freeman leads Regulatory Behavioral Science at Sanofi Consumer Healthcare to ensure social/behavioral science data is fit for regulatory decision-making.